262 related articles for article (PubMed ID: 25901944)
1. Structural basis for the targeting of complement anaphylatoxin C5a using a mixed L-RNA/L-DNA aptamer.
Yatime L; Maasch C; Hoehlig K; Klussmann S; Andersen GR; Vater A
Nat Commun; 2015 Apr; 6():6481. PubMed ID: 25901944
[TBL] [Abstract][Full Text] [Related]
2. A functional C5a anaphylatoxin receptor in a teleost species.
Holland MC; Lambris JD
J Immunol; 2004 Jan; 172(1):349-55. PubMed ID: 14688343
[TBL] [Abstract][Full Text] [Related]
3. C5L2, a nonsignaling C5A binding protein.
Okinaga S; Slattery D; Humbles A; Zsengeller Z; Morteau O; Kinrade MB; Brodbeck RM; Krause JE; Choe HR; Gerard NP; Gerard C
Biochemistry; 2003 Aug; 42(31):9406-15. PubMed ID: 12899627
[TBL] [Abstract][Full Text] [Related]
4. The orphan receptor C5L2 has high affinity binding sites for complement fragments C5a and C5a des-Arg(74).
Cain SA; Monk PN
J Biol Chem; 2002 Mar; 277(9):7165-9. PubMed ID: 11773063
[TBL] [Abstract][Full Text] [Related]
5. A novel C5a-neutralizing mirror-image (l-)aptamer prevents organ failure and improves survival in experimental sepsis.
Hoehlig K; Maasch C; Shushakova N; Buchner K; Huber-Lang M; Purschke WG; Vater A; Klussmann S
Mol Ther; 2013 Dec; 21(12):2236-46. PubMed ID: 23887360
[TBL] [Abstract][Full Text] [Related]
6. Human C3a and C3a desArg anaphylatoxins have conserved structures, in contrast to C5a and C5a desArg.
Bajic G; Yatime L; Klos A; Andersen GR
Protein Sci; 2013 Feb; 22(2):204-12. PubMed ID: 23184394
[TBL] [Abstract][Full Text] [Related]
7. Structure of human desArg-C5a.
Cook WJ; Galakatos N; Boyar WC; Walter RL; Ealick SE
Acta Crystallogr D Biol Crystallogr; 2010 Feb; 66(Pt 2):190-7. PubMed ID: 20124699
[TBL] [Abstract][Full Text] [Related]
8. Signaling of the Complement Cleavage Product Anaphylatoxin C5a Through C5aR (CD88) Contributes to Pharmacological Hematopoietic Stem Cell Mobilization.
Bujko K; Rzeszotek S; Hoehlig K; Yan J; Vater A; Ratajczak MZ
Stem Cell Rev Rep; 2017 Dec; 13(6):793-800. PubMed ID: 28918528
[TBL] [Abstract][Full Text] [Related]
9. Aptamers that bind to the human complement component receptor hC5aR1 interfere with hC5aR1 interaction to its hC5a ligand.
Kumar PKR
Mol Biol Rep; 2018 Oct; 45(5):851-864. PubMed ID: 29981048
[TBL] [Abstract][Full Text] [Related]
10. Plasma clearance of the human C5a anaphylatoxin by binding to leucocyte C5a receptors.
Oppermann M; Götze O
Immunology; 1994 Aug; 82(4):516-21. PubMed ID: 7835913
[TBL] [Abstract][Full Text] [Related]
11. Functions of C5a receptors.
Ward PA
J Mol Med (Berl); 2009 Apr; 87(4):375-8. PubMed ID: 19189071
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-1 upregulates anaphylatoxin receptors on mononuclear cells.
Takabayashi T; Shimizu S; Clark BD; Beinborn M; Burke JF; Gelfand JA
Surgery; 2004 May; 135(5):544-54. PubMed ID: 15118592
[TBL] [Abstract][Full Text] [Related]
13. The role of the N-terminal domain of the complement fragment receptor C5L2 in ligand binding.
Scola AM; Higginbottom A; Partridge LJ; Reid RC; Woodruff T; Taylor SM; Fairlie DP; Monk PN
J Biol Chem; 2007 Feb; 282(6):3664-71. PubMed ID: 17158873
[TBL] [Abstract][Full Text] [Related]
14. Decreased survival of human breast cancer cells expressing HER2/neu on in vitro incubation with an anti-HER2/neu antibody fused to C5a or C5a desArg.
Fuenmayor J; Perez-Vazquez K; Perez-Witzke D; Penichet ML; Montano RF
Mol Cancer Ther; 2010 Aug; 9(8):2175-85. PubMed ID: 20682652
[TBL] [Abstract][Full Text] [Related]
15. The human mast cell line HMC-1 expresses C5a receptors and responds to C5a but not to C5a(desArg).
Werfel T; Oppermann M; Butterfield JH; Begemann G; Elsner J; Götze O; Zwirner J
Scand J Immunol; 1996 Jul; 44(1):30-6. PubMed ID: 8693289
[TBL] [Abstract][Full Text] [Related]
16. Use of capillary electrophoresis to select a DNA aptamer that recognizes swine anaphylatoxin C5a.
Li Z; Wang X; Chen M; Li Q; Qu H; Shao T; Sun R; Zhang Y; Xia Z
Anal Biochem; 2019 Jan; 564-565():47-53. PubMed ID: 30336124
[TBL] [Abstract][Full Text] [Related]
17. The emerging structural complexity of G-quadruplex RNAs.
Banco MT; Ferré-D'Amaré AR
RNA; 2021 Apr; 27(4):390-402. PubMed ID: 33483368
[TBL] [Abstract][Full Text] [Related]
18. Experimental design of complement component 5a-induced acute lung injury (C5a-ALI): a role of CC-chemokine receptor type 5 during immune activation by anaphylatoxin.
Russkamp NF; Ruemmler R; Roewe J; Moore BB; Ward PA; Bosmann M
FASEB J; 2015 Sep; 29(9):3762-72. PubMed ID: 25999468
[TBL] [Abstract][Full Text] [Related]
19. Modeling molecular mechanisms of binding of the anaphylatoxin C5a to the C5a receptor.
Nikiforovich GV; Marshall GR; Baranski TJ
Biochemistry; 2008 Mar; 47(10):3117-30. PubMed ID: 18275159
[TBL] [Abstract][Full Text] [Related]
20. Characterization of Anaphylatoxin Receptor Expression and C3a/C5a Functions in Anaphylatoxin Receptor Reporter Mice.
Laumonnier Y; Karsten CM; Köhl G; Köhl J
Curr Protoc Immunol; 2020 Sep; 130(1):e100. PubMed ID: 32710701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
